The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pituitary Cancer Market Research Report 2025
Synopsis
Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
The global Pituitary Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
This report aims to provide a comprehensive presentation of the global market for Pituitary Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pituitary Cancer.
Report Scope
The Pituitary Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pituitary Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pituitary Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Trinity Biotech
Salzman
Genentech
Sigma-Aldrich
Varian Medical Systems
Elekta
Accuray Incorporated
Ion Beam Applications
Nordion
Becton Dickinson
Isoray Medical
RaySearch Laboratories
Mevion Medical Systems
Segment by Type
Blood Tests
Urine Test
Brain Imaging
Vision Testing
Segment by Application
Hospital
Clinics
Diagnostic Centers
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pituitary Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
The global Pituitary Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.
This report aims to provide a comprehensive presentation of the global market for Pituitary Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pituitary Cancer.
Report Scope
The Pituitary Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pituitary Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pituitary Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Trinity Biotech
Salzman
Genentech
Sigma-Aldrich
Varian Medical Systems
Elekta
Accuray Incorporated
Ion Beam Applications
Nordion
Becton Dickinson
Isoray Medical
RaySearch Laboratories
Mevion Medical Systems
Segment by Type
Blood Tests
Urine Test
Brain Imaging
Vision Testing
Segment by Application
Hospital
Clinics
Diagnostic Centers
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pituitary Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pituitary Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Tests
1.2.3 Urine Test
1.2.4 Brain Imaging
1.2.5 Vision Testing
1.3 Market by Application
1.3.1 Global Pituitary Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pituitary Cancer Market Perspective (2019-2030)
2.2 Pituitary Cancer Growth Trends by Region
2.2.1 Global Pituitary Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pituitary Cancer Historic Market Size by Region (2019-2024)
2.2.3 Pituitary Cancer Forecasted Market Size by Region (2025-2030)
2.3 Pituitary Cancer Market Dynamics
2.3.1 Pituitary Cancer Industry Trends
2.3.2 Pituitary Cancer Market Drivers
2.3.3 Pituitary Cancer Market Challenges
2.3.4 Pituitary Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pituitary Cancer Players by Revenue
3.1.1 Global Top Pituitary Cancer Players by Revenue (2019-2024)
3.1.2 Global Pituitary Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Pituitary Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pituitary Cancer Revenue
3.4 Global Pituitary Cancer Market Concentration Ratio
3.4.1 Global Pituitary Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pituitary Cancer Revenue in 2023
3.5 Pituitary Cancer Key Players Head office and Area Served
3.6 Key Players Pituitary Cancer Product Solution and Service
3.7 Date of Enter into Pituitary Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pituitary Cancer Breakdown Data by Type
4.1 Global Pituitary Cancer Historic Market Size by Type (2019-2024)
4.2 Global Pituitary Cancer Forecasted Market Size by Type (2025-2030)
5 Pituitary Cancer Breakdown Data by Application
5.1 Global Pituitary Cancer Historic Market Size by Application (2019-2024)
5.2 Global Pituitary Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pituitary Cancer Market Size (2019-2030)
6.2 North America Pituitary Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pituitary Cancer Market Size by Country (2019-2024)
6.4 North America Pituitary Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pituitary Cancer Market Size (2019-2030)
7.2 Europe Pituitary Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pituitary Cancer Market Size by Country (2019-2024)
7.4 Europe Pituitary Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pituitary Cancer Market Size (2019-2030)
8.2 Asia-Pacific Pituitary Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pituitary Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Pituitary Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pituitary Cancer Market Size (2019-2030)
9.2 Latin America Pituitary Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pituitary Cancer Market Size by Country (2019-2024)
9.4 Latin America Pituitary Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pituitary Cancer Market Size (2019-2030)
10.2 Middle East & Africa Pituitary Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pituitary Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Pituitary Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Trinity Biotech
11.1.1 Trinity Biotech Company Detail
11.1.2 Trinity Biotech Business Overview
11.1.3 Trinity Biotech Pituitary Cancer Introduction
11.1.4 Trinity Biotech Revenue in Pituitary Cancer Business (2019-2024)
11.1.5 Trinity Biotech Recent Development
11.2 Salzman
11.2.1 Salzman Company Detail
11.2.2 Salzman Business Overview
11.2.3 Salzman Pituitary Cancer Introduction
11.2.4 Salzman Revenue in Pituitary Cancer Business (2019-2024)
11.2.5 Salzman Recent Development
11.3 Genentech
11.3.1 Genentech Company Detail
11.3.2 Genentech Business Overview
11.3.3 Genentech Pituitary Cancer Introduction
11.3.4 Genentech Revenue in Pituitary Cancer Business (2019-2024)
11.3.5 Genentech Recent Development
11.4 Sigma-Aldrich
11.4.1 Sigma-Aldrich Company Detail
11.4.2 Sigma-Aldrich Business Overview
11.4.3 Sigma-Aldrich Pituitary Cancer Introduction
11.4.4 Sigma-Aldrich Revenue in Pituitary Cancer Business (2019-2024)
11.4.5 Sigma-Aldrich Recent Development
11.5 Varian Medical Systems
11.5.1 Varian Medical Systems Company Detail
11.5.2 Varian Medical Systems Business Overview
11.5.3 Varian Medical Systems Pituitary Cancer Introduction
11.5.4 Varian Medical Systems Revenue in Pituitary Cancer Business (2019-2024)
11.5.5 Varian Medical Systems Recent Development
11.6 Elekta
11.6.1 Elekta Company Detail
11.6.2 Elekta Business Overview
11.6.3 Elekta Pituitary Cancer Introduction
11.6.4 Elekta Revenue in Pituitary Cancer Business (2019-2024)
11.6.5 Elekta Recent Development
11.7 Accuray Incorporated
11.7.1 Accuray Incorporated Company Detail
11.7.2 Accuray Incorporated Business Overview
11.7.3 Accuray Incorporated Pituitary Cancer Introduction
11.7.4 Accuray Incorporated Revenue in Pituitary Cancer Business (2019-2024)
11.7.5 Accuray Incorporated Recent Development
11.8 Ion Beam Applications
11.8.1 Ion Beam Applications Company Detail
11.8.2 Ion Beam Applications Business Overview
11.8.3 Ion Beam Applications Pituitary Cancer Introduction
11.8.4 Ion Beam Applications Revenue in Pituitary Cancer Business (2019-2024)
11.8.5 Ion Beam Applications Recent Development
11.9 Nordion
11.9.1 Nordion Company Detail
11.9.2 Nordion Business Overview
11.9.3 Nordion Pituitary Cancer Introduction
11.9.4 Nordion Revenue in Pituitary Cancer Business (2019-2024)
11.9.5 Nordion Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Detail
11.10.2 Becton Dickinson Business Overview
11.10.3 Becton Dickinson Pituitary Cancer Introduction
11.10.4 Becton Dickinson Revenue in Pituitary Cancer Business (2019-2024)
11.10.5 Becton Dickinson Recent Development
11.11 Isoray Medical
11.11.1 Isoray Medical Company Detail
11.11.2 Isoray Medical Business Overview
11.11.3 Isoray Medical Pituitary Cancer Introduction
11.11.4 Isoray Medical Revenue in Pituitary Cancer Business (2019-2024)
11.11.5 Isoray Medical Recent Development
11.12 RaySearch Laboratories
11.12.1 RaySearch Laboratories Company Detail
11.12.2 RaySearch Laboratories Business Overview
11.12.3 RaySearch Laboratories Pituitary Cancer Introduction
11.12.4 RaySearch Laboratories Revenue in Pituitary Cancer Business (2019-2024)
11.12.5 RaySearch Laboratories Recent Development
11.13 Mevion Medical Systems
11.13.1 Mevion Medical Systems Company Detail
11.13.2 Mevion Medical Systems Business Overview
11.13.3 Mevion Medical Systems Pituitary Cancer Introduction
11.13.4 Mevion Medical Systems Revenue in Pituitary Cancer Business (2019-2024)
11.13.5 Mevion Medical Systems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
